Avanos Medical, Inc. (NYSE:AVNS) Shares Acquired by Tower Research Capital LLC TRC

Tower Research Capital LLC TRC grew its stake in Avanos Medical, Inc. (NYSE:AVNS) by 493.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 8,075 shares of the company’s stock after acquiring an additional 6,714 shares during the period. Tower Research Capital LLC TRC’s holdings in Avanos Medical were worth $129,000 as of its most recent filing with the SEC.

Several other large investors have also recently made changes to their positions in the stock. Barclays PLC raised its position in Avanos Medical by 446.2% in the third quarter. Barclays PLC now owns 96,194 shares of the company’s stock valued at $2,311,000 after purchasing an additional 78,583 shares during the period. JPMorgan Chase & Co. grew its stake in shares of Avanos Medical by 6.9% in the third quarter. JPMorgan Chase & Co. now owns 69,571 shares of the company’s stock valued at $1,672,000 after buying an additional 4,472 shares in the last quarter. Tributary Capital Management LLC raised its holdings in shares of Avanos Medical by 38.1% in the 4th quarter. Tributary Capital Management LLC now owns 893,008 shares of the company’s stock valued at $14,217,000 after buying an additional 246,379 shares during the period. Empowered Funds LLC lifted its stake in Avanos Medical by 141.3% during the 4th quarter. Empowered Funds LLC now owns 153,834 shares of the company’s stock worth $2,449,000 after acquiring an additional 90,091 shares in the last quarter. Finally, New York State Teachers Retirement System boosted its holdings in Avanos Medical by 4.0% during the 4th quarter. New York State Teachers Retirement System now owns 75,215 shares of the company’s stock valued at $1,197,000 after acquiring an additional 2,921 shares during the period. 95.17% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Avanos Medical

In other Avanos Medical news, SVP Kerr Holbrook sold 7,000 shares of the stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $15.25, for a total value of $106,750.00. Following the transaction, the senior vice president now directly owns 82,047 shares in the company, valued at $1,251,216.75. This represents a 7.86 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 2.64% of the stock is currently owned by corporate insiders.

Avanos Medical Stock Performance

NYSE:AVNS opened at $12.59 on Thursday. The company has a market cap of $579.27 million, a price-to-earnings ratio of 37.04 and a beta of 1.13. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. Avanos Medical, Inc. has a 52 week low of $11.84 and a 52 week high of $25.36. The company has a fifty day simple moving average of $13.53 and a two-hundred day simple moving average of $16.21.

Avanos Medical (NYSE:AVNS) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.07. The company had revenue of $167.50 million for the quarter, compared to the consensus estimate of $161.75 million. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. Avanos Medical’s revenue was up .8% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.22 EPS. As a group, equities analysts anticipate that Avanos Medical, Inc. will post 1.32 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, StockNews.com raised shares of Avanos Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, March 19th.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.